Detalhe da pesquisa
1.
Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases.
Circ J
; 85(4): 333-342, 2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536399
2.
[Evaluation of the Efficacy and Safety of Platinum Doublet Re-Challenge Chemotherapy in Patients with Recurrent Advanced Non-Small Cell Lung Cancer].
Gan To Kagaku Ryoho
; 43(6): 723-6, 2016 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-27306808
3.
A family of distal arthrogryposis type 5 due to a novel PIEZO2 mutation.
Am J Med Genet A
; 167A(5): 1100-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712306
4.
Doctor's delay in endobronchial tuberculosis.
Kekkaku
; 88(1): 9-13, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23513562
5.
A 65-Year-Old Man With Massive Hemoptysis.
Chest
; 164(1): e9-e13, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423707
6.
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Ther Adv Med Oncol
; 14: 17588359221116603, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35923924
7.
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Ther Adv Med Oncol
; 14: 17588359221142786, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36570411
8.
[A case of tuberculous pleurisy developing contralateral effusion during anti-tuberculosis chemotherapy].
Kekkaku
; 86(7): 723-7, 2011 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-21922782
9.
An autopsy case report of yellow nail syndrome coincided with primary biliary cholangitis.
Respir Med Case Rep
; 32: 101332, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33511030
10.
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
Ther Adv Med Oncol
; 13: 1758835921998588, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717228
11.
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.
JAMA Oncol
; 6(7): e201250, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407455
12.
Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema.
Respir Med Case Rep
; 28: 100940, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31667076
13.
A successful pembrolizumab treatment case of lung adenocarcinoma after becoming resistant to ALK-TKI treatment due to G1202R mutation.
Respir Investig
; 56(4): 365-368, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30008296
14.
Pulmonary Adenocarcinoma, Harboring Both an EGFR Mutation and ALK Rearrangement, Presenting a Stable Disease to Erlotinib and a Partial Response to Alectinib.
Intern Med
; 57(16): 2377-2382, 2018 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29526950
15.
Six Cases of Pulmonary Mycobacterium shinjukuense Infection at a Single Hospital.
Intern Med
; 55(7): 787-91, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27041166
16.
Relationship Between Lung Cancer and Mycobacterium Avium Complex Isolated Using Bronchoscopy.
Open Respir Med J
; 10: 20-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27335625